Patient Guide: An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 21 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06169579
Status: 🟢 Enrolling Now
Condition: Advanced Solid Tumor
Phase: Phase I

Find a Study Location Near You

This study is available at 21 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Xiamen, Fujian
  • Lanzhou, Gansu
  • Lanzhou, Gansu
  • • And 18 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily